Altamira Therapeutics Ltd (CYTO)
1.54
-0.02
(-1.28%)
USD |
NASDAQ |
May 17, 16:00
1.56
+0.02
(+1.30%)
After-Hours: 20:00
Altamira Therapeutics Total Assets (Quarterly): 9.160M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 9.160M |
| June 30, 2023 | 6.899M |
| June 30, 2023 | 6.899M |
| December 31, 2022 | 6.798M |
| June 30, 2022 | 19.36M |
| June 30, 2022 | 19.36M |
| December 31, 2021 | 20.97M |
| June 30, 2021 | 25.77M |
| June 30, 2021 | 25.77M |
| December 31, 2020 | 23.81M |
| June 30, 2020 | 8.373M |
| June 30, 2020 | 8.373M |
| December 31, 2019 | 9.522M |
| June 30, 2019 | 12.01M |
| December 31, 2018 | 10.03M |
| September 30, 2018 | 8.204M |
| June 30, 2018 | 7.485M |
| March 31, 2018 | 16.56M |
| Date | Value |
|---|---|
| December 31, 2017 | 18.30M |
| September 30, 2017 | 23.62M |
| June 30, 2017 | 30.42M |
| March 31, 2017 | 37.05M |
| December 31, 2016 | 35.04M |
| September 30, 2016 | 42.43M |
| June 30, 2016 | 36.63M |
| March 31, 2016 | 45.48M |
| December 31, 2015 | 53.43M |
| September 30, 2015 | 59.71M |
| June 30, 2015 | 68.32M |
| March 31, 2015 | 53.78M |
| December 31, 2014 | 60.16M |
| September 30, 2014 | 67.99M |
| June 30, 2014 | 17.14M |
| March 31, 2014 | 23.52M |
| December 31, 2013 | 29.58M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
6.798M
Minimum
Dec 2022
25.77M
Maximum
Jun 2021
14.51M
Average
10.77M
Median
Total Assets (Quarterly) Benchmarks
| Kiniksa Pharmaceuticals Ltd | 519.67M |
| Tiziana Life Sciences Ltd | 12.18M |
| Landos Biopharma Inc | 29.90M |
| Masimo Corp | 2.958B |
| AbbVie Inc | 148.87B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.471M |
| Shareholders Equity (Quarterly) | 7.690M |
| Current Ratio | 1.376 |
| Net Debt Paydown Yield | 31.93% |